White House expects Covid vaccinations for children under age 5 to begin as early as June 21

White House expects Covid vaccinations for children under age 5 to begin as early as June 21


A nurse administers a pediatric dose of the Covid-19 vaccine to a girl at a L.A. Care Health Plan vaccination clinic at Los Angeles Mission College in the Sylmar neighborhood in Los Angeles, California, January 19, 2022.

Robyn Beck | AFP | Getty Images

Covid vaccinations for children under age 5 are expected to begin as early as June 21, a senior Biden administration health official said on Thursday.

Dr. Ashish Jha, the White House Covid response coordinator, said the Biden administration will initially make 10 million doses of Pfizer and Moderna vaccines available to states, pharmacies and community health centers. States can begin placing orders on Friday, Jha said, but the vaccine doses will ship only after the Food and Drug Administration authorizes the shots.

The FDA is expected to make its decision on Pfizer and Moderna’s Covid shots for infants through preschoolers soon after the agency’s committee of independent experts reviews the data on June 15, Jha said. The Centers for Disease Control and Prevention would then issue its recommendations quickly after the FDA decision, which would allow vaccinations to begin after the Juneteenth federal holiday, he said.

Jha said it will take some time for the vaccination program to ramp up but every parent should be able to get an appointment within weeks of the initial rollout.

“We’re going to ship doses out as fast as possible,” Jha told reporters during White House press briefing. “We’re going to make sure that supply is always meeting demand. And we’re going to do everything we can to make it easy for providers and parents alike to get their kids vaccinated.”

Parents have been waiting months for the FDA to authorize the shots for kids under age 5, which is the only group left in the U.S. that is not yet eligible for Covid vaccination. Though Covid is normally less severe in children than adults, hospitalizations of kids under age 5 were five times higher during the winter omicron surge compared to the peak during the previous delta wave, according to the CDC.

Pfizer said its three-dose vaccine for children ages 6 months through 4 years old was 80% effective at preventing illness from the omicron variant. The shots are three micrograms, one-tenth the dosage level for adults.

Moderna said its two-dose vaccine was about 51% effective against infection from omicron in children under 2 years old and about 37% effective among kids 2 through 5 years old. However, Moderna Chief Medical Officer Dr. Paul Burton said the antibody levels observed in the children should translate to high levels of protection against severe illness. Moderna’s shots are 25 micrograms, much smaller than the 100 micrograms currently approved for adults.

If FDA authorizes the shots in June, parents would have a few months to get their kids vaccinated ahead of the fall. Public health officials are expecting another wave of Covid infection around that time as people start to spend more time indoors as the weather turns colder.

This is breaking news. Please check back for updates.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:



Source

Genentech to sell flu pill directly to some consumers at a discount as Trump pressures drugmakers
Health

Genentech to sell flu pill directly to some consumers at a discount as Trump pressures drugmakers

A sign is posted in front of a Genentech office on June 12, 2025 in South San Francisco, California. Justin Sullivan | Getty Images Roche‘s Genentech on Thursday said it will sell its flu pill, Xofluza, directly to certain patients at a discount in a bid to expand access, becoming the latest company to wade […]

Read More
DuPont prepares to say goodbye to electronics. What investors get with the remaining company
Health

DuPont prepares to say goodbye to electronics. What investors get with the remaining company

Earlier in the week, we looked at the upcoming DuPont electronics business spinoff and what investors are getting with the new Qnity Electronics, which has a strong foothold in the semiconductor industry. Now, here is a look at what will be left of the new DuPont after the planned Nov. 1 split and the stocks […]

Read More
Abbott’s quarter disappoints again: We’re downgrading it and considering what to do next
Health

Abbott’s quarter disappoints again: We’re downgrading it and considering what to do next

Shares of Abbott Laboratories fell 3% on Wednesday after the diversified health-care company delivered another less-than-stellar quarter. Revenue in the third quarter ended Sept. 30 rose 6.9% to $11.37 billion, missing the $11.4 billion consensus estimate compiled by market data provider LSEG. Organic sales , excluding Covid testing results, rose 7.5%, beating the 5.9% estimate, […]

Read More